Pharmacokinetics, Pharmacodynamics and Safety of Tolvaptan, A Novel, Oral, Selective Nonpeptide AVP V2-receptor Antagonist: Results of Single- and Multiple-Dose Studies in Healthy Japanese Male Volunteers - Concepedia

Concepedia

Publication | Closed Access

Pharmacokinetics, Pharmacodynamics and Safety of Tolvaptan, A Novel, Oral, Selective Nonpeptide AVP V2-receptor Antagonist: Results of Single- and Multiple-Dose Studies in Healthy Japanese Male Volunteers

52

Citations

8

References

2011

Year

Seong Ryul Kim, Tomoko Hasunuma, Osamu Satō, Tadashi Okada, Mitsuhiro Kondo, Junichi Azuma

Cardiovascular Drugs and Therapy

Molecular PharmacologyPharmacological StudyA NovelPharmacologyNeuropharmacologyClinical PharmacologyPharmacotherapyMultiple-dose StudiesMedicine

References

	Year	Citations

Page 1